NIAID Banner Logo Image

HIV Citation List: October 15 - October 29, 2008


1. Yu H, Tudor D, Alfsen A, Labrosse B, Clavel F, Bomsel M.

Peptide P5 (residues 628-683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection.

Retrovirology. 2008 Oct 16;5(1):93. [Epub ahead of print]

PMID: 18925934 [PubMed - as supplied by publisher]

2. He Y, Cheng J, Lu H, Li J, Hu J, Qi Z, Liu Z, Jiang S, Dai Q.

Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains.

Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16332-7. Epub 2008 Oct 13.

PMID: 18852475 [PubMed - in process]

3. Chen KX, Xie HY, Li ZG, Gao JR.

Quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-HIV agents.

Bioorg Med Chem Lett. 2008 Oct 15;18(20):5381-6. Epub 2008 Sep 18.

PMID: 18835162 [PubMed - in process]


HIV or AIDS and Compound or Therapeutic

4. Giffin MJ, Heaslet H, Brik A, Lin YC, Cauvi G, Wong CH, McRee DE, Elder JH, Stout CD, Torbett BE.

A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant.

J Med Chem. 2008 Oct 23;51(20):6263-70. Epub 2008 Sep 30.

PMID: 18823110 [PubMed - in process]

HIV or AIDS and Drug

5. Ghosh AK, Gemma S, Takayama J, Baldridge A, Leshchenko-Yashchuk S, Miller HB, Wang YF, Kovalevsky AY, Koh Y, Weber IT, Mitsuya H.

Potent HIV-1 protease inhibitors incorporating meso-bicyclic urethanes as P2-ligands: structure-based design, synthesis, biological evaluation and protein-ligand X-ray studies.

Org Biomol Chem. 2008 Oct 21;6(20):3703-13. Epub 2008 Aug 11.

PMID: 18843400 [PubMed - in process]

6. Wendeler M, Lee HF, Bermingham A, Miller JT, Chertov O, Bona MK, Baichoo NS, Ehteshami M, Beutler J, O'Keefe BR, Götte M, Kvaratskhelia M, Le Grice S.

Vinylogous ureas as a novel class of inhibitors of reverse transcriptase-associated ribonuclease H activity.

ACS Chem Biol. 2008 Oct 17;3(10):635-44. Epub 2008 Oct 3.

PMID: 18831589 [PubMed - in process]

7. Kazmierski WM, Aquino C, Chauder BA, Deanda F, Ferris R, Jones-Hertzog DK, Kenakin T, Koble CS, Watson C, Wheelan P, Yang H, Youngman M.

Discovery of bioavailable 4,4-disubstituted piperidines as potent ligands of the chemokine receptor 5 and inhibitors of the human immunodeficiency virus-1.

J Med Chem. 2008 Oct 23;51(20):6538-46. Epub 2008 Sep 24.

PMID: 18811134 [PubMed - in process]

HIV or AIDS and Inhibition

8. Raza A, Sham YY, Vince R.

Design and synthesis of sulfoximine based inhibitors for HIV-1 protease.

Bioorg Med Chem Lett. 2008 Oct 15;18(20):5406-10. Epub 2008 Sep 13.

PMID: 18829317 [PubMed - in process]

HIV or AIDS and class

9. Jessen HJ, Balzarini J, Meier C.

Intracellular Trapping of cycloSal-Pronucleotides: modification of prodrugs with amino acid esters.

J Med Chem. 2008 Oct 23;51(20):6592-8. Epub 2008 Oct 1.

PMID: 18826203 [PubMed - in process]

Journal Check

10. Ghosh AK, Gemma S, Baldridge A, Wang YF, Kovalevsky AY, Koh Y, Weber IT, Mitsuya H.

Flexible cyclic ethers/polyethers as novel P2-ligands for HIV-1 protease inhibitors: design, synthesis, biological evaluation, and protein-ligand X-ray studies.

J Med Chem. 2008 Oct 9;51(19):6021-33. Epub 2008 Sep 11.

PMID: 18783203 [PubMed - in process]

11. Zhan P, Liu X, Cao Y, Wang Y, Pannecouque C, De Clercq E.

1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

Bioorg Med Chem Lett. 2008 Oct 15;18(20):5368-71. Epub 2008 Sep 18.

PMID: 18824350 [PubMed - in process]

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2024